Forging the Fate of Cellular Therapies for Cardiovascular Disease.


The field of cell therapy for cardiovascular disease has progressed at an uneven rate and will likely follow the translational paths of other biological therapies. The field will require novel public–private partnerships to guide it to its ultimate applications. The long process of developing new therapeutics for cardiovascular disease may often seem like a… (More)
DOI: 10.1161/CIRCRESAHA.117.310970


  • Presentations referencing similar topics